MTFB - Motif Bio submits Type B meeting request to FDA
- Motif Bio (NASDAQ:MTFB) has submitted a meeting request and package to the FDA for iclaprim.
- More news on: Motif Bio plc, Healthcare stocks news, Read more ...
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get MTFB Alerts
News, Short Squeeze, Breakout and More Instantly...